Showing results (1751-1760 of 1,877) with videos related to

Sort By:
Pageof 188
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2013
The translocation t(4;14) can be present only in minor subclones in multiple myelomaBenjamin Hébraud, Denis Caillot, Jill Corre, et al.
Blood|July 16, 2021
Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONEJesus San-Miguel, Hervé Avet-Loiseau, Bruno Paiva, et al.
British Journal of Haematology|June 21, 2019
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trialEileen M Boyle, Xavier Leleu, Marie-Odile Petillon, et al.
Leukemia & Lymphoma|July 13, 2017
Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteriaGuillemette Fouquet, Kym Ie Snell, Stéphanie Guidez, et al.
Leukemia|July 13, 2007
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trialsP Moreau, M Attal, F Garban, et al.
Blood|January 16, 2013
Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02Xavier Leleu, Michel Attal, Bertrand Arnulf, et al.
Bone Marrow Transplantation|November 4, 2014
Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective studyK Gagne, P Loiseau, V Dubois, et al.
The New England Journal of Medicine|April 6, 2017
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for MyelomaMichel Attal, Valerie Lauwers-Cances, Cyrille Hulin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1Thomas Graillon, Pauline Romanet, Clara Camilla, et al.
Blood|February 16, 2022
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical featuresTitouan Cazaubiel, Xavier Leleu, Aurore Perrot, et al.
Pageof 188